JY
MIRA icon

Jeff Yass’s MIRA Pharmaceuticals MIRA Stock Holding History

Jeff Yass’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Sell
18,566
-6,580
-26% -$6.66K ﹤0.01% 13068
2026
Q1 		$26.9K Buy
+25,146
New +$31.5K ﹤0.01% 12793
2024
Q2 		– Sell
-15,573
Closed -$17.1K – 12787
2024
Q1 		$17.1K Buy
+15,573
New +$16.9K ﹤0.01% 11850

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's MIRA Position: Q2 2026 in Review

Jeff Yass reduced its MIRA Pharmaceuticals (MIRA) stake by 26% in Q2 2026, selling an estimated $6.66K and leaving 18,566 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #13068.

Jeff Yass first reported a position in MIRA in Q1 2024 and has held it in 3 quarters since. The position peaked at $26.9K in Q1 2026. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Jeff Yass held 18,566 shares of MIRA Pharmaceuticals worth $17.6K as of Q2 2026.
  • Jeff Yass sold 6,580 MIRA Pharmaceuticals shares in Q2 2026, an estimated $6.66K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13068 holding.
  • Jeff Yass first reported a position in MIRA Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • Jeff Yass's MIRA Pharmaceuticals position peaked at $26.9K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.